Ocella Pill Manufacturers Show Disregard for Women
December 3rd, 2009Drospirenone is just one of the elements assigned to the onslaught of Yaz side effects reported regularly in America. Drospirenone is an ingredient allegedly unlike other progestins in the United States and was not found in America before it made an appearance in Yasmin, Yaz and Ocella. Add in the fact that the FDA issued warning letter to the makers of Ocella, Yasmin and Yaz for using low-quality batches of drospirenone from Germany and you have the makings of a cautionary tale involving Big Pharma and its disregard for the wellbeing of the individuals utilizing its products.
Among the different tilts impending on Yasmin, Yaz and Ocella birth control, the contraceptives also contain drospirenone, an element not in other oral contraceptives. The British Medical Journal issued studies in August 2009 recording an increased risk of venous blood clots in women taking drospirenone as opposed to those who took other oral contraceptives. In the same month, the FDA issued an non-related advisory to Bayer Pharmaceuticals, makers of Yasmin, for using low-quality batches of drospirenone from a plant in Germany. For the benefit of public interest and well-being, these studies have been made available free online.
Any women that have been hurt as a result of taking Yaz, Yasmin or Ocella may be eligible to compensation. Many lawyers and legal counsel agencies such as thelegaladvocate.com now provide assistance to anyone experiencing side effects and health issues as a direct result of using Yasmin contraception. Now that more women across the United States are coming forward and filing lawsuits, the legal system is moving closer to rendering justice for those who were misinformed by the birth control manufacturers and possibly their doctors.


